The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Ocugen Inc (NASDAQ: OCGN) was $1.63 for the day, up 1.87% from the previous closing price of $1.6. In other words, the price has increased by $1.87 from its previous closing price. On the day, 6.73 million shares were traded. OCGN stock price reached its highest trading level at $1.68 during the session, while it also had its lowest trading level at $1.51.
Ratios:
Our analysis of OCGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.83 and its Current Ratio is at 1.83. In the meantime, Its Debt-to-Equity ratio is 10.76 whereas as Long-Term Debt/Eq ratio is at 10.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 15, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On March 01, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.50.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.Mizuho initiated its Buy rating on August 23, 2022, with a $5 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 09 ’25 when MARNA C. WHITTINGTON bought 112,205 shares for $1.10 per share.
PRABHAVATHI FERNANDES bought 146,705 shares of OCGN for $171,029 on Jun 11 ’25. On Nov 26 ’24, another insider, Fernandes Prabhavathi, who serves as the Director of the company, bought 10,000 shares for $0.91 each. As a result, the insider paid 9,095 and bolstered with 10,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 509056704 and an Enterprise Value of 482266720. For the stock, the TTM Price-to-Sale (P/S) ratio is 107.17 while its Price-to-Book (P/B) ratio in mrq is 155.98. Its current Enterprise Value per Revenue stands at 101.444 whereas that against EBITDA is -9.214.
Stock Price History:
The Beta on a monthly basis for OCGN is 4.19, which has changed by 0.7358892 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, OCGN has reached a high of $1.90, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 28.93%, while the 200-Day Moving Average is calculated to be 76.73%.
Shares Statistics:
OCGN traded an average of 4.35M shares per day over the past three months and 8124040 shares per day over the past ten days. A total of 312.31M shares are outstanding, with a floating share count of 307.30M. Insiders hold about 1.60% of the company’s shares, while institutions hold 16.54% stake in the company. Shares short for OCGN as of 1759190400 were 52777098 with a Short Ratio of 12.13, compared to 1756425600 on 54538456. Therefore, it implies a Short% of Shares Outstanding of 52777098 and a Short% of Float of 17.16.
Earnings Estimates
The firm’s stock currently is rated by 4.0 analysts. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.2 and -$0.24 for the fiscal current year, implying an average EPS of -$0.21. EPS for the following year is -$0.23, with 4.0 analysts recommending between -$0.16 and -$0.28.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for OCGN’s current fiscal year. The highest revenue estimate was $5.4M, while the lowest revenue estimate was $2.85M, resulting in an average revenue estimate of $3.77M. In the same quarter a year ago, actual revenue was $4.05M
